Abstract
The objective of this study was to develop an ocular drug delivery system built on the cationic liposomes, a novel bioadhesive colloidal system, which could enhance the precorneal residence time, ocular permeation, and bioavailability of ibuprofen. The optimal formulation of cationic liposomes prepared by ethanol injection method was ultimately confirmed by an orthogonal L9 (33) test design. In addition, γ-scintigraphic technology and the microdialysis technique were utilized in the assessment of in vivo precorneal retention capability and ocular bioavailability individually. In the end, we acquired the optimal formulation of ibuprofen cationic liposomes (Ibu-CL) by orthogonal test design, and the particle size and entrapment efficiency (EE%) were 121.0 ± 3.5 nm and 72.9 ± 3.4%, respectively. In comparison to ibuprofen eye drops (Ibu-ED), Ibu-CL could significantly prolong the T max to 100 min and the AUC to 1.53-folds, which indicated that the Ibu-CL could improve the precorneal retention time and bioavailability of ibuprofen. Consequently, these outcomes designated that the ibuprofen cationic liposomes we researched probably are a promising application in ocular drug delivery system.
Similar content being viewed by others
References
Ali J, Fazil M, Qumbar M, Khan N, Ali A. Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv. 2016;23(3):710–26. https://doi.org/10.3109/10717544.2014.923065.
He L, Xu H, Nie S, Yang X, Yin J, Pan W. Optimized flurbiprofen cationic liposomes in situ gelling system of thermosensitive polymers for ocular delivery. J Appl Polym Sci. 2012;123(6):3363–74. https://doi.org/10.1002/app.33883.
Liu S, Jones L, Gu FX. Nanomaterials for ocular drug delivery. Macromol Biosci. 2012;12(5):608–20. https://doi.org/10.1002/mabi.201100419.
De Sa FA, Taveira SF, Gelfuso GM, Lima EM, Gratieri T. Liposomal voriconazole (VOR) formulation for improved ocular delivery. Colloids Surf B: Biointerfaces. 2015;133:331–8. https://doi.org/10.1016/j.colsurfb.2015.06.036.
Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348–60. https://doi.org/10.1208/s12248-010-9183-3.
Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 2002;16(1–2):53–61. https://doi.org/10.1016/S0928-0987(02)00057-X.
Shi JJ, Xiao ZY, Kamaly N, Farokhzad OC. Self-assembled targeted nanoparticles:evolution of technologies and bench to bedside translation. Acc Chem Res. 2011;44(10):1123–34. https://doi.org/10.1021/ar200054n.
Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013;9(1):1–14. https://doi.org/10.1016/j.nano.2012.05.013.
Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615–27. https://doi.org/10.1038/nrd2591.
Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine—challenge and perspectives. Angew Chem Int Ed. 2009;48(5):872–97. https://doi.org/10.1002/anie.200802585/full.
Zylberberg C, Matosevic S. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv. 2016;23(9):3319–29. https://doi.org/10.1080/10717544.2016.1177136.
Wei M, Xu Y, Zou Q, Tu L, Tang C, Xu T, et al. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. Eur J Pharm Sci. 2012;46(3):131–41. https://doi.org/10.1016/j.ejps.2012.02.007.
Kaur CD, Nahar M, Jain NK. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target. 2008;16(10):798–805. https://doi.org/10.1080/10611860802475688.
Hayashi T, Onodera R, Tahara K, Takeuchi H. Novel approaches for posterior segment ocular drug delivery with folate-modified liposomal formulation. Asian J Pharml Sci. 2016;11(1):201–2. https://doi.org/10.1016/j.ajps.2015.11.036.
Zhang Y, Ren J, Ma R, An Y, Shi L. Synthesis and research on pH and redox dual responsive UV-cross-linked micelle. J Control Release. 2015;213:e131–e2. https://doi.org/10.1016/j.jconrel.2015.05.222.
Rohiwal SS, Satvekar RK, Tiwari AP, Raut AV, Kumbhar SG, Pawar SH. Investigating the influence of effective parameters on molecular characteristics of bovine serum albumin nanoparticles. Appl Surf Sci. 2015;334:157–64. https://doi.org/10.1016/j.apsusc.2014.08.170.
Chu DF, Gao J, Wang ZJ. Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection. ACS Nano. 2015;9:11800–11. https://doi.org/10.1021/acsnano.5b05583.
Wang Z, Li J, Cho J, Malik AB. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat Nanotechnol. 2014;9(3):204–10. https://doi.org/10.1038/nnano.2014.17.
Tabernero A, Gonzalez-Garcinuno A, Sanchez-Alvarez JM, Galan MA, Martin Del Valle EM. Development of a nanoparticle system based on a fructose polymer: stability and drug release studies. Carbohydr Polym. 2017;160:26–33. https://doi.org/10.1016/j.carbpol.2016.12.025.
Liu Q, Zhan C, Kohane DS. Phototriggered drug delivery using inorganic nanomaterials. Bioconjug Chem. 2017;28(1):98–104. https://doi.org/10.1021/acs.bioconjchem.6b00448.
Mehra NK, Palakurthi S. Interactions between carbon nanotubes and bioactives: a drug delivery perspective. Drug Discov Today. 2016;21(4):585–97. https://doi.org/10.1016/j.drudis.2015.11.011.
Chen S, Hao X, Liang X, Zhang Q, Zhang C, Zhou G, et al. Inorganic nanomaterials as carriers for drug delivery. J Biomed Nanotechnol. 2016;12(1):1–27. https://doi.org/10.1166/jbn.2016.2122.
Cortesi R, Argnani R, Esposito E, Dalpiaz A, Scatturin A, Bortolotti F. Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int J Pharm. 2006;317(1):90–100. https://doi.org/10.1016/j.ijpharm.2006.02.050.
He W, Guo X, Feng M, Mao N. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. Int J Pharm. 2013;458(2):305–14. https://doi.org/10.1016/j.ijpharm.2013.10.033.
Helene E, Schaeffer DLK. Liposomes in topical drug delivery. Investig Ophthalmol Vis Sci. 1982;22(2):220–7.
Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20(3):228–43. https://doi.org/10.3109/08982100903347923.
Oku N, Namba Y, Takeda A, Okada S. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes. Nucl Med Biol. 1993;20(4):407–12. https://doi.org/10.1016/0969-8051(93)90071-2.
Li X, Nie SF, Kong J, Li N, Ju CY, Pan WS. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm. 2008;363(1–2):177–82. https://doi.org/10.1016/j.ijpharm.2008.07.017.
Wei G, Xu H, Ding PT, Li SM, Zheng JM. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release. 2002;83(1):65–74. https://doi.org/10.1016/S0168-3659(02)00175-X.
Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm. 1999;180(2):185–93. https://doi.org/10.1016/S0378-5173(99)00003-4.
Huang HS, Schoenwald RD, Lach JL. Corneal penetration behavior of β-blocking agents I: physicochemical factors. J Pharm Sci. 1983;72(11):1266–72. https://doi.org/10.1002/jps.2600721108.
Zhang HH, Luo QH, Yang ZJ, Pan WS, Nie SF. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo. Drug Deliv. 2011;18(7):502–10. https://doi.org/10.3109/10717544.2011.595839.
Koklic T. Perifosine induced release of contents of trans cell-barrier transport efficient liposomes. Chem Phys Lipids. 2014;183:50–9. https://doi.org/10.1016/j.chemphyslip.2014.05.006.
Araujo J, Gonzalez E, Egea MA, Garcia ML, Souto EB. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine. 2009;5(4):394–401. https://doi.org/10.1016/j.nano.2009.02.003.
Ran C, Chen D, Xu M, Du C, Li Q, Jiang Y. A study on characteristic of different sample pretreatment methods to evaluate the entrapment efficiency of liposomes. J Chromatogr B Anal Technol Biomed Life Sci. 2016;1028:56–62. https://doi.org/10.1016/j.jchromb.2016.06.008.
Hathout RMMS, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies. AAPS PharmSciTech. 2007;8(1):1.
PR. BAC. Membrane fusion with cationic liposomes: effects of target membrane lipid composition. Biochemistry. 1997;36(7):1628–34. https://doi.org/10.1021/bi961173x.
Alvarado HL, Abrego G, Garduno-Ramirez ML, Clares B, Calpena AC, Garcia ML. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications. Nanomedicine. 2015;11(3):521–30. https://doi.org/10.1016/j.nano.2015.01.004.
Liu Z, Yang XG, Li X, Pan W, Li J. Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev Ind Pharm. 2007;33(12):1327–31. https://doi.org/10.1080/03639040701397241.
Acknowledgments
This study was supported by the program of supporting career development of young and middle-aged teachers from Shenyang Pharmaceutical University (ZQN2015011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors confirm that there are no known conflicts of interest associated with this publication.
Rights and permissions
About this article
Cite this article
Gai, X., Cheng, L., Li, T. et al. In vitro and In vivo Studies on a Novel Bioadhesive Colloidal System: Cationic Liposomes of Ibuprofen. AAPS PharmSciTech 19, 700–709 (2018). https://doi.org/10.1208/s12249-017-0872-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-017-0872-4